Efficient Synthesis of Biologically Active Natural Products Useful for Drug Discovery
Project/Area Number |
22249001
|
Research Category |
Grant-in-Aid for Scientific Research (A)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Chemical pharmacy
|
Research Institution | Nagasaki University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
ISHIHARA Jun 長崎大学, 医歯薬学総合研究科, 准教授 (80250413)
TAKAHASHI Keisuke 長崎大学, 医歯薬学総合研究科, 助教 (60380854)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥49,140,000 (Direct Cost: ¥37,800,000、Indirect Cost: ¥11,340,000)
Fiscal Year 2012: ¥10,270,000 (Direct Cost: ¥7,900,000、Indirect Cost: ¥2,370,000)
Fiscal Year 2011: ¥14,430,000 (Direct Cost: ¥11,100,000、Indirect Cost: ¥3,330,000)
Fiscal Year 2010: ¥24,440,000 (Direct Cost: ¥18,800,000、Indirect Cost: ¥5,640,000)
|
Keywords | 全合成 / 天然物 / オキサゾロマイシン / ウエルウィスタチン / カイトセファリン / オキゾロマイシン |
Research Abstract |
We have studied on the total synthesis of natural products having intriguing biological activities useful for drug discovery. As a result, we have achieved the total syntheses of oxazolomycin A and kitocephalin, and the formal synthesis of welwistatin. In addition, we have developed a new methodology for the construction of heterocycles which relies on a Rh(II)-catalyzed C-H amination reaction, and have achieved the total syntheses of NW-G01, englerin A, and inthomycin A, B, C.
|
Report
(4 results)
Research Products
(43 results)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] エングレリンA の全合成2011
Author(s)
高橋圭介,横井裕一,小嶺敬太,石原 淳,畑山 範
Organizer
第37回反応と合成の進歩シンポジウム
Place of Presentation
徳島
Year and Date
2011-11-07
Related Report
-
-
-
[Presentation] Total Synthesis of Chloptosin2010
Author(s)
Setsuya Shibahara, Takaaki Matsubara, Keishke Takahashi, Jun Ishihara, Susumi Hatakeyama
Organizer
The 2010 International Chemical Congressof Pacific Basin Societies
Place of Presentation
Hawaii (USA)
Year and Date
2010-12-19
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-